EIC Pathfinder Challenge: Biotechnology for Healthy Ageing 2026

The EIC Pathfinder Challenge: Biotechnology for Healthy Ageing 2026 funds early-stage, deep-tech research to translate ageing research into tangible biopharmaceutical solutions. Projects must target fundamental molecular/cellular ageing mechanisms rather than treating individual diseases. Three target areas: innovative preventative/therapeutic biotech interventions for age-related diseases, biomarker-based tools for deploying ageing interventions responsibly, and New Approach Methodologies (NAMs) for healthy ageing development. Funding up to €4 million per project with access to Business Acceleration Services. Portfolio-based evaluation - proposals assessed on scientific merit and contribution to a balanced, complementary portfolio.

Vem kan ansöka

Open to research consortia of at least 2 independent entities from EU Member States or Horizon Europe Associated Countries. UK entities are eligible. Focus on biotech/pharma interventions, biomarker tools, or NAMs for healthy ageing.

Förmåner & fördelar

Business Acceleration Services (coaching, mentoring, networking)
Booster grants for commercialization testing (€50,000)
Access to EIC Programme Managers for strategic guidance
Portfolio collaboration opportunities
Regulatory and ethical guidance integration support

Nyckelkontakter

EIC Support Desk
General Support
[email protected]
EIC Programme Managers
Challenge-specific enquiries
[email protected]

Källor

Länkar som AI använde för att samla information om detta bidrag.